Pre-Paid Phone Distribution: A Tool for Improving Healthcare Engagement for People with Substance Use Disorder

References

• Ahmad, F. B., Rossen, L. M., & Sutton, P. (2021). Provisional drug overdose data. National Center for Health Statistic. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm
   Google Scholar
• Ashford, R., Lynch, K., & Curtis, B. (2018). Technology and social media use among patients enrolled in outpatient addiction treatment programs: Cross-sectional survey study. Journal of Medical Internet Research, 20(3), e84. https://www.jmir.org/2018/3/e84/ https://doi.org/10.2196/jmir.9172
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2021, March 17). Understanding the epidemic. https://www.cdc.gov/drugoverdose/epidemic/index.html
   Google Scholar
• Centers for Medicare & Medicaid Services. (n.d.). Telemedicine. Retrieved January 3, 2023, from https://www.medicaid.gov/medicaid/benefits/telemedicine/index.html
   Google Scholar
• Chang, J. E., Lindenfeld, Z., Thomas, T., Waldman, J., & Griffin, J. (2022). Patient characteristics associated with phone versus video telemedicine visits for substance use treatment during COVID-19. Journal of Addiction Medicine, 16(6), 659–665. https://doi.org/10.1097/ADM.0000000000000985
   PubMedGoogle Scholar
• Haley, D. F., & Saitz, R. (2020). The opioid epidemic during the COVID-19 pandemic. JAMA, 324(16), 1615–1617. https://doi.org/10.1001/jama.2020.18543
   PubMed Web of Science ®Google Scholar
• Harris, M. T. H., Peterkin, A., Bach, P., Englander, H., Lapidus, E., Rolley, T., Weimer, M. B., & Weinstein, Z. M. (2021). Adapting inpatient addiction medicine consult services during the COVID-19 pandemic. Addiction science & Clinical Practice, 16(1), 13. https://doi.org/10.1186/s13722-021-00221-1
   PubMed Web of Science ®Google Scholar
• Johns Hopkins Coronavirus Resource Center. (2022). COVID-19 Map. https://coronavirus.jhu.edu/map.html
   Google Scholar
• Joudrey, P. J., Edelman, E. J., & Wang, E. A. (2019). Drive times to opioid treatment programs in urban and rural counties in 5 US states. JAMA, 322(13), 1310–1312. https://doi.org/10.1001/jama.2019.12562
   PubMed Web of Science ®Google Scholar
• Kazevman, G., Mercado, M., Hulme, J., & Somers, A. (2021). Prescribing phones to address health equity needs in the COVID-19 era: The PHONE-CONNECT program. Journal of Medical Internet Research, 23(4), e23914. https://doi.org/10.2196/23914
   PubMed Web of Science ®Google Scholar
• King, C., Vega, T., Button, D., Nicolaidis, C., Gregg, J., & Englander, H. (2021). Understanding the impact of the SARS-COV-2 pandemic on hospitalized patients with substance use disorder. PloS ONE, 16(2), e0247951. https://doi.org/10.1371/journal.pone.0247951
   PubMed Web of Science ®Google Scholar
• Komaromy, M., Tomanovich, M., Taylor, J. L., Ruiz-Mercado, G., Kimmel, S. D., Bagley, S. M., Saia, K. M., Costello, E., Park, T. W., LaBelle, C., Weinstein, Z., & Walley, A. Y. (2021). Adaptation of a system of treatment for substance use disorders during the COVID-19 pandemic. Journal of Addiction Medicine, 15(6), 448–451. https://doi.org/10.1097/ADM.0000000000000791
   PubMed Web of Science ®Google Scholar
• Masson, C. L., Chen, I. Q., Levine, J. A., Shopshire, M. S., & Sorensen, J. L. (2019). Health-related internet use among opioid treatment patients. Addictive behaviors Reports, 9, 100157. https://doi.org/10.1016/j.abrep.2018.100157
   PubMedGoogle Scholar
• Milward, J., Day, E., Wadsworth, E., Strang, J., & Lynskey, M. (2015). Mobile phone ownership, usage and readiness to use by patients in drug treatment. Drug and Alcohol Dependence, 146, 111–115. https://doi.org/10.1016/j.drugalcdep.2014.11.001
   PubMed Web of Science ®Google Scholar
• Mitchell, S. G., Schwartz, R. P., Alvanzo, A. A. H., Weisman, M. S., Kyle, T. L., Turrigiano, E. M., Gibson, M. L., Perez, L., McClure, E. A., Clingerman, S., Froias, A., Shandera, D. R., Walker, R., Babcock, D. L., Bailey, G. L., Miele, G. M., Kunkel, L. E., Norton, M., & Stitzer, M. L. (2015). The use of technology in participant tracking and study retention: Lessons learned from a clinical trials network study. Substance abuse, 36(4), 420–426. https://doi.org/10.1080/08897077.2014.992565
   PubMed Web of Science ®Google Scholar
• Pew Research Center. (2019). Mobile Technology and Home Broadband 2019. https://www.pewresearch.org/internet/2019/06/13/mobile-technology-and-home-broadband-2019/
   Google Scholar
• Stewart, C., Kopinski, H., Liebschutz, J., Holmdahl, I., Keosaian, J., Herman, D., Anderson, B., & Stein, M. (2018). The provision of cell phones as a recruitment and retention strategy for people who inject drugs enrolling in a randomized trial. Drug and Alcohol Dependence, 184, 20–25. https://doi.org/10.1016/j.drugalcdep.2017.11.019
   PubMed Web of Science ®Google Scholar
• Stowe, M. J., Calvey, T., Scheibein, F., Arya, S., Saad, N. A., Shirasaka, T., Dannatt, L., Ghosh, A., Yee, A., Ratta-Apha, W., Vadivel, R., Siste, K., Shah, B., Ramalho, R., Narasimha, V. L., Delic, M., Peyron, E., Onoria, J. L. Gumikiriza., Pant, S. B., … Morgan, N. (2020). Access to healthcare and harm reduction services during the COVID-19 pandemic for people who use drugs. Journal of Addiction Medicine, 14(6), e287–e289. https://doi.org/10.1097/ADM.0000000000000753
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. (2016). Rural behavioral health: Telehealth challenges and opportunities. In Brief, 9(2): 1–13. https://store.samhsa.gov/sites/default/files/d7/priv/sma16-4989.pdf
   Google Scholar
• Substance Abuse and Mental Health Services Administration. (2020).FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency. . https://www.samhsa.gov/sites/default/files/faqs-for-oud-prescribing-and-dispensing.pdf
   Google Scholar
• Tofighi, B., McNeely, J., Walzer, D., Fansiwala, K., Demner, A., Chaudhury, C. S., Subudhi, I., Schatz, D., Reed, T., & Krawczyk, N. (2022). A telemedicine buprenorphine clinic to serve New York City: Initial evaluation of the NYC public hospital system’s initiative to expand treatment access during the COVID-19 pandemic. Journal of Addiction Medicine, 16(1), e40–e43. https://doi.org/10.1097/ADM.0000000000000809
   PubMed Web of Science ®Google Scholar
• Verma, S. (2020). Early impact of CMS expansion of medicare telehealth during COVID-19. Health Affairs Blog, July 15. 1–10. https://www.healthaffairs.org/do/10.1377/hblog20200715.454789/full/
   Google Scholar
• Wang, Q. Q., Kaelber, D. C., Xu, R., & Volkow, N. D. (2021). COVID-19 risk and outcomes in patients with substance use disorders: Analyses from electronic health records in the United States. Molecular Psychiatry, 26(1): 30–39. Article1. https://doi.org/10.1038/s41380-020-00880-7
   Google Scholar
• Wang, L., Weiss, J., Ryan, E. B., Waldman, J., Rubin, S., & Griffin, J. L. (2021). Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic. Journal of Substance Abuse Treatment, 124, 108272. https://doi.org/10.1016/j.jsat.2020.108272
   PubMed Web of Science ®Google Scholar